We are live on ! Find out more
StoneX Group

StoneX Group Portfolio holdings

AUM $2.75B Turnover 58.43%
1-Year Est. Return 24.25%
 

StoneX Group is a financial services firm that has six lines of business: foreign exchange, securities, physical commodities, global payments, commercial hedging, and clearing and execution services. It was known as INTL FCStone until 2020, a name chosen in 2011 after International Assets Holding Corporation merged with FCStone Group. In 2019 it launched a prime brokerage division that clears trades for hedge funds, mutual funds and family offices. In 2020 StoneX agreed to buy GAIN Capital, the operator of the Forex.com and City Index retail trading brands.

This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+24.25%
3 Year Est. Return
+92.46%
5 Year Est. Return
+94.65%
10 Year Est. Return
+286.67%
AUM
$2.75B
AUM Growth
+$267M
Cap. Flow
+$299M
Cap. Flow %
10.87%
Top 10 Hldgs %
25.44%
Holding
2,403
New
939
Increased
616
Reduced
368
Closed
465
Avg Time Held
1.3 years
Top 10 Avg Time Held
3.9 years
Top 20 Avg Time Held
2.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 69.27%
2 Technology 9.13%
3 Financials 7.69%
4 Industrials 2.87%
5 Healthcare 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CTXR icon
1751
Citius Pharmaceuticals
CTXR
$15.1M
$20K ﹤0.01%
+36,414
New +$21.5K
2026 Q3
0 quarters
ESYN icon
1752
EnerSyn Global Inc. Common Stock
ESYN
$11.6M
$19.8K ﹤0.01%
+13,935
New +$24.2K
2026 Q3
0 quarters
YFOR
1753
YYForce Inc. Class A Ordinary Shares
YFOR
$1M
$19.7K ﹤0.01%
+13,769
New +$18.8K
2026 Q3
0 quarters
QTEX icon
1754
QTREX Quantum
QTEX
$67.7M
$19.7K ﹤0.01%
+21,898
New +$22.1K
2026 Q3
0 quarters
ISPC icon
1755
iSpecimen
ISPC
$2.12M
$19.6K ﹤0.01%
+16,008
New +$30.2K
2026 Q3
0 quarters
SRFM icon
1756
Surf Air Mobility
SRFM
$98.3M
$19.5K ﹤0.01%
+18,364
New +$14.3K
2026 Q3
0 quarters
HCAT icon
1757
Health Catalyst
HCAT
$120M
$19.5K ﹤0.01%
+10,492
New +$20K
2026 Q3
0 quarters
AXNX icon
1758
Axonex AI Group Limited Class A Ordinary Shares
AXNX
$6.28M
$19.3K ﹤0.01%
+8,262
New +$33.2K
2026 Q3
0 quarters
CHAI icon
1759
Core AI Holdings Inc
CHAI
$4.74M
$19.2K ﹤0.01%
+57,127
New +$20.6K
2026 Q3
0 quarters
PDSB icon
1760
PDS Biotechnology
PDSB
$94.2M
$19.2K ﹤0.01%
+37,592
New +$21.4K
2026 Q3
0 quarters
DOUG icon
1761
Douglas Elliman
DOUG
$152M
$19.1K ﹤0.01%
+12,553
New +$22.6K
2026 Q3
0 quarters
ORBS icon
1762
Eightco Holdings
ORBS
$333M
$18.9K ﹤0.01%
+24,747
New +$19.7K
2026 Q3
0 quarters
ALLR icon
1763
Allarity Therapeutics
ALLR
$17.2M
$18.8K ﹤0.01%
+17,388
New +$21.8K
2026 Q3
0 quarters
DMAAR icon
1764
Drugs Made In America Acquisition Corp Rights
DMAAR
$18.6K ﹤0.01%
+141,536
New +$19.4K
2026 Q3
0 quarters
TOPS icon
1765
TOP Ships
TOPS
$2.26M
$18.4K ﹤0.01%
+30,855
New +$23.2K
2026 Q3
0 quarters
SLGB icon
1766
Smart Logistics Global
SLGB
$9.9M
$18.4K ﹤0.01%
40,509
+29,061
+254% +$14.8K
2026 Q2
1 quarter
OCGN icon
1767
Ocugen
OCGN
$297M
$18.2K ﹤0.01%
+14,543
New +$18.5K
2026 Q3
0 quarters
CHRS icon
1768
Coherus Oncology
CHRS
$131M
$18.2K ﹤0.01%
+13,454
New +$18.4K
2026 Q3
0 quarters
MDAI icon
1769
Spectral AI
MDAI
$49.2M
$18.1K ﹤0.01%
11,034
-4,309
-28% -$7.06K
2026 Q2
1 quarter
INV icon
1770
Innventure Inc
INV
$18.7M
$17.4K ﹤0.01%
+13,514
New +$32.1K
2026 Q3
0 quarters
BFRG icon
1771
Bullfrog AI
BFRG
$9.8M
$17.4K ﹤0.01%
31,262
+12,692
+68% +$7.5K
2026 Q1
2 quarters
XELAP icon
1772
DELISTED
Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock
XELAP
$17K ﹤0.01%
399,282
+1,585
+0.4% +$68
2024 Q4
7 quarters
RFAMR icon
1773
RF Acquisition Corp III Rights
RFAMR
$17K ﹤0.01%
148,907
-187,429
-56% -$22.5K
2026 Q1
2 quarters
GAIA icon
1774
Gaia
GAIA
$32.5M
$16.9K ﹤0.01%
+12,776
New +$21.2K
2026 Q3
0 quarters
RDZN icon
1775
Roadzen
RDZN
$92.8M
$16.5K ﹤0.01%
+13,436
New +$17.3K
2026 Q3
0 quarters

Similar funds

StoneX Group's Q3 2026 Portfolio in Review

As of Q3 2026, StoneX Group held 2,403 positions worth $2.75B, up 11% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

StoneX Group deployed $299M of net new capital in Q3 2026, opening 939 new positions and adding to 616 existing holdings. Its largest new stake was iShares MSCI ACWI ETF: 90,830 shares worth $14.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 70% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $16.1M trimmed.

  • StoneX Group's largest Q3 2026 buy was iShares MSCI ACWI ETF: 90,830 shares worth $14.4M.
  • StoneX Group added most to iShares Semiconductor ETF in Q3 2026, an estimated $27.9M increase.
  • StoneX Group's biggest Q3 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $16.1M.
  • StoneX Group fully exited KT in Q3 2026, selling an estimated $25.8M.
  • StoneX Group's ten largest holdings make up 25% of its $2.75B portfolio in Q3 2026.
  • StoneX Group opened 939 new positions and closed 465 in Q3 2026.
  • StoneX Group's portfolio value rose 11% quarter-over-quarter to $2.75B.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.